Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
6.21
+0.35 (5.97%)
At close: Jul 2, 2026, 4:00 PM EDT
6.09
-0.12 (-1.93%)
After-hours: Jul 2, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $8.04 million as of July 2, 2026. Its market cap has decreased by -48.96% in one year.
Market Cap
8.04M
Enterprise Value
3.69M
1-Year Change
-48.96%
Ranking
Category
Stock Price
$6.21
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $8.04M, a decrease of -97.70%. That is a compound annual growth rate of -59.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 8.04M | -43.26% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 9.18M |
| TransCode Therapeutics | 8.18M |
| Imunon | 8.03M |
| Immuron | 7.93M |
| Kairos Pharma | 7.92M |
| Bolt Biotherapeutics | 7.78M |
| PharmaCyte Biotech | 7.68M |
| MetaVia | 7.64M |